TipRanks
MDxHealth (GB:0O8G)
LSE:0O8G
UK Market
0O8G
MDxHealth
RESEARCH TOOLSreports

MDxHealth (0O8G) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0O8G Analyst Ratings

Hold
5Ratings
Hold
1 Buy
4 Hold
0 Sell
Based on 5 analysts giving stock ratings to
MDxHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0O8G Stock 12 Month Forecast

Average Price Target

€0.67
▼(-77.84% Downside)
Based on 5 Wall Street analysts offering 12 month price targets for MDxHealth in the last 3 months. The average price target is €0.67 with a high forecast of €0.89 and a low forecast of €0.45. The average price target represents a -77.84% change from the last price of €3.02.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"€4","-1":"-€1","0.25":"€0.25","1.5":"€1.5","2.75":"€2.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.89240377,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€0.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.6693028275,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€0.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.446201885,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€0.45</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.25,1.5,2.75,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.019,2.8554156746153847,2.6918313492307693,2.528247023846154,2.3646626984615384,2.201078373076923,2.0374940476923076,1.8739097223076924,1.710325396923077,1.5467410715384615,1.383156746153846,1.2195724207692307,1.0559880953846155,{"y":0.89240377,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.019,2.8382540636538462,2.6575081273076924,2.4767621909615385,2.2960162546153846,2.1152703182692307,1.934524381923077,1.7537784455769232,1.5730325092307693,1.3922865728846154,1.2115406365384616,1.0307947001923077,0.850048763846154,{"y":0.6693028275,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.019,2.821092452692308,2.6231849053846155,2.425277358076923,2.227369810769231,2.0294622634615385,1.8315547161538461,1.6336471688461538,1.4357396215384615,1.2378320742307691,1.0399245269230768,0.8420169796153845,0.6441094323076921,{"y":0.446201885,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.019,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.019,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€0.89Average Price Target€0.67Lowest Price Target€0.45
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on GB:0O8G
Mark Massaro
BTIG
BTIG
€1.78→
Hold
―
Downgraded
10/19/26
MDxHealth downgraded to Neutral from Buy at BTIGMDxHealth downgraded to Neutral from Buy at BTIG
Craig-Hallum Analyst forecast on GB:0O8G
William Bonello
Craig-Hallum
Craig-Hallum
―
Hold
―
Downgraded
10/16/26
MDxHealth downgraded to Hold from Buy at Craig-HallumMDxHealth downgraded to Hold from Buy at Craig-Hallum
Lake Street Analyst forecast on GB:0O8G
Thomas Flaten
Lake Street
Lake Street
€2.68→€0.45
Hold
-85.23%
Downside
Downgraded
10/16/26
MDxHealth downgraded to Hold from Buy at Lake StreetMDxHealth downgraded to Hold from Buy at Lake Street
William Blair Analyst forecast on GB:0O8G
Matt Larew
William Blair
William Blair
―
Hold
―
Reiterated
08/14/26
Analysts Offer Insights on Healthcare Companies: MDxHealth (NASDAQ: MDXH), Opko Health (NASDAQ: OPK) and Zenas BioPharma, Inc. (NASDAQ: ZBIO)
TD Cowen Analyst forecast on GB:0O8G
Daniel Brennan
TD Cowen
TD Cowen
€0.89
Buy
-70.45%
Downside
Reiterated
08/13/26
MDxHealth Earns Buy Rating on Strengthened Balance Sheet, Improved Margins, and Reaffirmed 2026 Growth and Profitability Targets
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on GB:0O8G
Mark Massaro
BTIG
BTIG
€1.78→
Hold
―
Downgraded
10/19/26
MDxHealth downgraded to Neutral from Buy at BTIGMDxHealth downgraded to Neutral from Buy at BTIG
Craig-Hallum Analyst forecast on GB:0O8G
William Bonello
Craig-Hallum
Craig-Hallum
―
Hold
―
Downgraded
10/16/26
MDxHealth downgraded to Hold from Buy at Craig-HallumMDxHealth downgraded to Hold from Buy at Craig-Hallum
Lake Street Analyst forecast on GB:0O8G
Thomas Flaten
Lake Street
Lake Street
€2.68→€0.45
Hold
-85.23%
Downside
Downgraded
10/16/26
MDxHealth downgraded to Hold from Buy at Lake StreetMDxHealth downgraded to Hold from Buy at Lake Street
William Blair Analyst forecast on GB:0O8G
Matt Larew
William Blair
William Blair
―
Hold
―
Reiterated
08/14/26
Analysts Offer Insights on Healthcare Companies: MDxHealth (NASDAQ: MDXH), Opko Health (NASDAQ: OPK) and Zenas BioPharma, Inc. (NASDAQ: ZBIO)
TD Cowen Analyst forecast on GB:0O8G
Daniel Brennan
TD Cowen
TD Cowen
€0.89
Buy
-70.45%
Downside
Reiterated
08/13/26
MDxHealth Earns Buy Rating on Strengthened Balance Sheet, Improved Margins, and Reaffirmed 2026 Growth and Profitability Targets
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MDxHealth

3 Months
Daniel BrennanTD Cowen
Success Rate
4/12 ratings generated profit
33%
Average Return
-4.23%
Copying Daniel Brennan's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -4.23% per trade.
1 Year
Daniel BrennanTD Cowen
Success Rate
2/12 ratings generated profit
17%
Average Return
-45.98%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -45.98% per trade.
2 Years
Daniel BrennanTD Cowen
Success Rate
1/12 ratings generated profit
8%
Average Return
-79.57%
Copying Daniel Brennan's trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -79.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0O8G Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
4
5
3
3
2
Buy
1
1
0
0
0
Hold
1
1
1
1
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
7
4
4
6
In the current month, 0O8G has received 2 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 0O8G average Analyst price target in the past 3 months is 0.67.
Each month's total comprises the sum of three months' worth of ratings.

0O8G Financial Forecast

0O8G Earnings Forecast

Next quarter’s earnings estimate for 0O8G is -€0.08 with a range of -€0.10 to -€0.05. The previous quarter’s EPS was -€0.16. 0O8G beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0O8G has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0O8G is -€0.08 with a range of -€0.10 to -€0.05. The previous quarter’s EPS was -€0.16. 0O8G beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0O8G has Performed in-line its overall industry.

0O8G Sales Forecast

Next quarter’s sales forecast for 0O8G is €25.59M with a range of €25.35M to €26.09M. The previous quarter’s sales results were €24.23M. 0O8G beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0O8G has Performed in-line its overall industry.
Next quarter’s sales forecast for 0O8G is €25.59M with a range of €25.35M to €26.09M. The previous quarter’s sales results were €24.23M. 0O8G beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0O8G has Performed in-line its overall industry.

0O8G Stock Forecast FAQ

What is GB:0O8G’s average 12-month price target, according to analysts?
Based on analyst ratings, MDxHealth’s 12-month average price target is 0.67.
    What is GB:0O8G’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GB:0O8G, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is MDxHealth a Buy, Sell or Hold?
        MDxHealth has a consensus rating of Hold, which is based on 1 buy ratings, 4 hold ratings and 0 sell ratings.
          What is MDxHealth’s share price target?
          The average share price target for MDxHealth is 0.67. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €0.89 ,and the lowest forecast is €0.45. The average share price target represents -77.84% Decrease from the current price of €3.02.
            What do analysts say about MDxHealth?
            MDxHealth’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of MDxHealth?
              To buy shares of GB:0O8G, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.